F13A1
Basic information
Region (hg38): 6:6144084-6321013
Previous symbols: [ "F13A" ]
Links
Phenotypes
GenCC
Source:
- congenital factor XIII deficiency (Supportive), mode of inheritance: AR
- factor XIII, A subunit, deficiency of (Definitive), mode of inheritance: AR
- factor XIII, A subunit, deficiency of (Definitive), mode of inheritance: AR
- factor XIII, A subunit, deficiency of (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Factor XIIIA deficiency | AR | Hematologic; Pharmacogenomic | Individuals have increased bleeding and poor wound healing; awareness and management of bleeding risk in certain situations (eg, obstetric event or surgery) may decrease morbidity; Precautions should be taken related to certain agents that may provoke/worsen bleeding risk | Hematologic | 1644910; 8025280; 7727776; 8547636; 9459313; 10365735; 12072871; 12456499; 17393027; 19438481; 20108427; 21512576 |
ClinVar
This is a list of variants' phenotypes submitted to
- Factor XIII, A subunit, deficiency of (6 variants)
- not provided (3 variants)
- F13A1-related disorder (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the F13A1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 25 | ||||
missense | 62 | 76 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 1 | 4 | 2 | 7 | ||
non coding | 27 | 41 | 72 | |||
Total | 9 | 11 | 97 | 26 | 44 |
Highest pathogenic variant AF is 0.000230
Variants in F13A1
This is a list of pathogenic ClinVar variants found in the F13A1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-6144164-C-G | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6144366-A-G | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 17, 2018) | ||
6-6144452-A-C | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6144484-C-T | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6144574-G-C | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6144589-C-A | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6144624-C-A | Factor XIII, A subunit, deficiency of | Benign (Jan 12, 2018) | ||
6-6144653-C-A | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6144674-A-G | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6144685-C-T | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6144692-C-T | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6144823-C-T | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6144876-C-T | Factor XIII, A subunit, deficiency of | Benign (Jan 13, 2018) | ||
6-6144991-C-T | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6144992-C-T | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6145000-G-A | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6145013-A-G | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6145032-C-T | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6145176-C-T | Factor XIII, A subunit, deficiency of | Likely benign (Jan 12, 2018) | ||
6-6145191-G-T | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6145202-C-A | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 12, 2018) | ||
6-6145349-G-A | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6145398-C-T | Factor XIII, A subunit, deficiency of | Benign (Jan 13, 2018) | ||
6-6145411-A-G | Factor XIII, A subunit, deficiency of | Uncertain significance (Jan 13, 2018) | ||
6-6145459-C-T | Factor XIII, A subunit, deficiency of | Benign (Nov 11, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
F13A1 | protein_coding | protein_coding | ENST00000264870 | 14 | 176929 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.29e-8 | 0.998 | 125640 | 0 | 108 | 125748 | 0.000430 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.05 | 356 | 416 | 0.855 | 0.0000248 | 4826 |
Missense in Polyphen | 125 | 173.55 | 0.72027 | 2068 | ||
Synonymous | -0.773 | 175 | 162 | 1.08 | 0.0000104 | 1409 |
Loss of Function | 2.79 | 18 | 36.1 | 0.498 | 0.00000190 | 417 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000481 | 0.000481 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00203 | 0.00203 |
European (Non-Finnish) | 0.000388 | 0.000352 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl- epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. {ECO:0000269|PubMed:27363989}.;
- Disease
- DISEASE: Factor XIII subunit A deficiency (FA13AD) [MIM:613225]: An autosomal recessive hematologic disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women. {ECO:0000269|PubMed:1353995, ECO:0000269|PubMed:20179087, ECO:0000269|PubMed:24286209, ECO:0000269|PubMed:24329762, ECO:0000269|PubMed:24889649, ECO:0000269|PubMed:27363989}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Complement and coagulation cascades - Homo sapiens (human);Aminocaproic Acid Action Pathway;Tranexamic Acid Action Pathway;Urokinase Action Pathway;Reteplase Action Pathway;Streptokinase Action Pathway;Tenecteplase Action Pathway;Alteplase Action Pathway;Anistreplase Action Pathway;Aprotinin Action Pathway;Phenindione Action Pathway;Dicoumarol Action Pathway;Warfarin Action Pathway;Acenocoumarol Action Pathway;Coagulation ;Bivalirudin Action Pathway;Argatroban Action Pathway;Ardeparin Action Pathway;Heparin Action Pathway;Fondaparinux Action Pathway;Enoxaparin Action Pathway;Phenprocoumon Action Pathway;Dicumarol Action Pathway;Ximelagatran Action Pathway;Lepirudin Action Pathway;Human Complement System;Interleukin-4 and 13 signaling;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis;Common Pathway of Fibrin Clot Formation;Formation of Fibrin Clot (Clotting Cascade);Alpha9 beta1 integrin signaling events;Beta1 integrin cell surface interactions
(Consensus)
Recessive Scores
- pRec
- 0.592
Intolerance Scores
- loftool
- 0.183
- rvis_EVS
- 0.25
- rvis_percentile_EVS
- 69.66
Haploinsufficiency Scores
- pHI
- 0.336
- hipred
- Y
- hipred_score
- 0.782
- ghis
- 0.421
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.739
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- F13a1
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; respiratory system phenotype;
Gene ontology
- Biological process
- platelet degranulation;blood coagulation;peptide cross-linking;cytokine-mediated signaling pathway;blood coagulation, fibrin clot formation
- Cellular component
- extracellular region;platelet alpha granule lumen;collagen-containing extracellular matrix;blood microparticle
- Molecular function
- protein-glutamine gamma-glutamyltransferase activity;metal ion binding